Home » Topics » Regulatory

Regulatory
RSS

Eybelis granted marketing approval for glaucoma and ocular hypertension in Japan

Sep. 25, 2018

Lorlatinib receives first approval in Japan

Sep. 21, 2018

Hulio, a biosimilar to adalimumab, receives marketing authorization in Europe

Sep. 21, 2018

FDA approves Ajovy for preventive treatment of migraine

Sep. 17, 2018

FDA approves Lumoxiti for relapsed or refractory hairy cell leukemia

Sep. 14, 2018

Ozalin becomes the first oral pediatric sedative to receive marketing authorization in Europe

Sep. 14, 2018

Elunate approved in China for colorectal cancer

Sep. 5, 2018

European Commission approves Cablivi for acquired thrombotic thrombocytopenic purpura

Sep. 3, 2018

FDA approves Merck & Co.'s Delstrigo and Pifeltro for the treatment of HIV-1

Aug. 31, 2018

European Commission approves Onpattro for hATTR with polyneuropathy

Aug. 31, 2018